Hypofractionated Postmastectomy RT Noninferior to Conventional PMRT

FRIDAY, Oct. 30, 2026 -- A 16-week course of hypofractionated postmastectomy radiation therapy (PMRT) is safe and noninferior to conventional PMRT, according to a study published online Oct. 12 in the Journal of Clinical Oncology.
Matthew M. Poppe...